サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：哺乳類細胞発酵技術の世界市場、規模調査・予測、タイプ別、用途別、最終用途別、地域別分析、2023～2030年
市場調査レポート
商品コード
1381797

哺乳類細胞発酵技術の世界市場、規模調査・予測、タイプ別、用途別、最終用途別、地域別分析、2023～2030年

Global Mammalian Cell Fermentation Technology Market Size Study & Forecast, by Type, By Application, By End-use and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
哺乳類細胞発酵技術の世界市場、規模調査・予測、タイプ別、用途別、最終用途別、地域別分析、2023～2030年
出版日: 2023年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の哺乳類細胞発酵技術市場は、2022年に約394億9,000万米ドルと評価され、予測期間2023～2030年には8.64％以上の成長率で成長すると予測されています。

哺乳類細胞発酵は、様々なバイオシミラー、酵素、ワクチン、その他の生物製剤の製造に広く利用されています。バイオ医薬品の開発には欠かせないステップです。哺乳動物細胞は、幹細胞から試験管内で生産された後、発酵のためにバイオリアクターで培養されます。この過程で、細胞は様々な代謝経路を用いて必須製品別を生産します。哺乳類細胞発酵技術の市場は、慢性疾患の有病率の増加、新規かつ安全な治療法に対するニーズの高まり、生物製剤やバイオシミラーに対する需要の高まりといった要因によって牽引されています。

さらに、がんを含む様々な慢性疾患の有病率の上昇が、がん治療にはモノクローナル抗体、治療用タンパク質、ワクチンなどの生物製剤の使用が多く含まれることから、市場成長の原動力となっています。哺乳類細胞発酵は、これらの複雑な生物製剤を生産するための重要な方法です。生物製剤の需要は、がんの有病率の上昇により上昇し、それが哺乳類細胞発酵技術の必要性を後押ししています。国際がん研究機関（IARC）によると、2021年には約190万件の新規症例が記録され、2040年には2,750万件の新規症例になると予測されています。生物製剤とバイオシミラーの需要が哺乳類細胞発酵技術市場を牽引しています。これらの治療法は、がん、自己免疫疾患、様々な慢性疾患など、多くの疾患への対応に不可欠です。2022年5月、Biocon Biologics Ltd.とViatris Inc.は、ロシュのAvastin（ベバシズマブ）のバイオシミラーであるAbevmy（ベバシズマブ）について、4つのがん適応症にわたってカナダ保健省から承認を取得しました。その結果、生物製剤とバイオシミラーの開拓が進み、市場成長の原動力となっています。さらに、技術の進歩や製薬企業による研究開発費の増加が、市場に新たな機会をもたらしています。しかし、技術開拓に伴う高コストが、予測期間2023～2030年の市場成長を抑制しています。

哺乳類細胞発酵技術の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、バイオ医薬品産業の存在感が強く、政府の規制が後押しし、医療インフラが整備されていることから、2022年の市場シェアは最大で、市場を独占しました。さらに、生物製剤やバイオシミラーに対する需要の増加、慢性疾患の有病率の上昇が、同地域の市場拡大に寄与しています。アジア太平洋は、患者数の多さ、生物学的製剤に対する需要の増加、バイオテクノロジー研究開発を支援する政府の取り組み、製造受託機関（CMO）の増加などの要因により、予測期間中に最も急成長する地域となる見込みです。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の哺乳類細胞発酵技術市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 哺乳類細胞発酵技術の世界市場力学

  • 哺乳類細胞発酵技術市場の影響分析（2020～2030年）
    • 市場促進要因
      • 慢性疾患の増加
      • 新規かつ安全な治療法に対するニーズの高まり
      • 生物製剤とバイオシミラーの需要拡大
    • 市場の課題
      • 哺乳類細胞発酵技術の高コスト
      • 厳しい政府規制
    • 市場機会
      • 技術の進歩
      • 研究開発費の増加

第4章 世界の哺乳類細胞発酵技術市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 哺乳類細胞発酵技術の世界市場：タイプ別

  • 市場スナップショット
  • 哺乳類細胞発酵技術の世界市場：タイプ別、実績・ポテンシャル分析
  • 哺乳類細胞発酵技術の世界市場：タイプ別、推定・予測、2020～2030年
  • 哺乳類細胞発酵技術市場、サブセグメント分析
    • ハムスター卵巣（CHO）細胞発酵
    • ヒト胚性腎臓（HEK）細胞発酵
    • ベビーハムスター腎臓（BHK）細胞発酵
    • マウス骨髄腫細胞発酵
    • その他

第6章 哺乳類細胞発酵技術の世界市場：用途別

  • 市場スナップショット
  • 哺乳類細胞発酵技術の世界市場：用途別、実績・ポテンシャル分析
  • 哺乳類細胞発酵技術の世界市場：用途別、推定・予測、2020～2030年
  • 哺乳類細胞発酵技術市場、サブセグメント分析
    • モノクローナル抗体
    • 組み換えタンパク質
    • ワクチン
    • ホルモン
    • 酵素
    • その他

第7章 哺乳類細胞発酵技術の世界市場：最終用途別

  • 市場スナップショット
  • 哺乳類細胞発酵技術の世界市場：最終用途別、実績・ポテンシャル分析
  • 哺乳類細胞発酵技術の世界市場：最終用途別、推定・予測、2020～2030年
  • 哺乳類細胞発酵技術市場、サブセグメント分析
    • バイオ医薬品企業
    • CMOおよびCDMO
    • 学術・研究機関

第8章 哺乳類細胞発酵技術の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 哺乳類細胞発酵技術市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別、推定・予測、2020～2030年
      • 用途別、推定・予測、2020～2030年
      • 最終用途別、推定・予測、2020～2030年
    • カナダ
  • 欧州の哺乳類細胞発酵技術市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の哺乳類細胞発酵技術市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの哺乳類細胞発酵技術市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東およびアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
    • Merck KGaA
    • Danaher Corporation
    • Lonza Group
    • Hoffmann-La Roche Ltd
    • Sartorius AG
    • AstraZeneca
    • Bristol-Myers Squibb
    • Amgen Inc.
    • Gilead Sciences Inc.

第10章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Mammalian Cell Fermentation Technology Market, report scope
  • TABLE 2. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Mammalian Cell Fermentation Technology Market estimates & forecasts by End Use 2020-2030 (USD Billion)
  • TABLE 6. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Mammalian Cell Fermentation Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Mammalian Cell Fermentation Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Mammalian Cell Fermentation Technology Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Mammalian Cell Fermentation Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Mammalian Cell Fermentation Technology Market
  • TABLE 71. List of primary sources, used in the study of global Mammalian Cell Fermentation Technology Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Mammalian Cell Fermentation Technology Market, research methodology
  • FIG 2. Global Mammalian Cell Fermentation Technology Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Mammalian Cell Fermentation Technology Market, key trends 2022
  • FIG 5. Global Mammalian Cell Fermentation Technology Market, growth prospects 2023-2030
  • FIG 6. Global Mammalian Cell Fermentation Technology Market, porters 5 force model
  • FIG 7. Global Mammalian Cell Fermentation Technology Market, pest analysis
  • FIG 8. Global Mammalian Cell Fermentation Technology Market, value chain analysis
  • FIG 9. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Mammalian Cell Fermentation Technology Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Mammalian Cell Fermentation Technology Market, regional snapshot 2020 & 2030
  • FIG 15. North America Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Mammalian Cell Fermentation Technology Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Mammalian Cell Fermentation Technology Market is valued at approximately USD 39.49 billion in 2022 and is anticipated to grow with a growth rate of more than 8.64% over the forecast period 2023-2030. Mammalian cell fermentation, is widely used to create a variety of biosimilars, enzymes, vaccines, and other biologics. It is an essential step in the development of biopharmaceuticals. Mammalian cells are cultured in a bioreactor for fermentation after being produced in vitro from stem cells. The essential byproducts are produced during this process by the cells using a variety of metabolic pathways. The market for Mammalian Cell Fermentation Technology is driven due to factors such as growing prevalence of chronic diseases, growing need for novel and secure therapies and the growing demand for biologics and biosimilars.

Additionally, the rising prevalence of various chronic diseases including cancer is driving the market growth as cancer treatment often involves the use of biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. Mammalian cell fermentation is a crucial method for producing these complex biologics. The demand for biologics rises due to the rising prevalence of cancer, which, in turn, drives the need for mammalian cell fermentation technology. According to the International Agency for Research on Cancer (IARC), it is estimated that there was an increase in the global burden of cancer in 2021 approximately 1.9 million new cases have been recorded, which is projected to account for 27.5 million new cases by 2040. Thus, this factor is propelling the demand for the development of personalized medicines, resulting in market growth, The demand for biologics and biosimilars is driving the market for mammalian cell fermentation technology. These therapies are essential for addressing a number of disorders, such as cancer, autoimmune diseases, and various chronic diseases. In May 2022, Biocon Biologics Ltd. and Viatris Inc. received approval from Health Canada for Abevmy (bevacizumab), a biosimilar to Roche's Avastin (bevacizumab), across four cancer indications. Consequentially, the rising development of biologics and biosimilars is driving market growth. Furthermore, rising technological advancement, as well as the increasing research and development spending by pharmaceutical companies are creating new opportunities to the market. However, the high cost associated with the development of technology is restraining the market growth in the forecast period 2023-2030.

The key regions considered for the Global Mammalian Cell Fermentation Technology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the region's strong biopharmaceutical industry presence, supportive government regulations, and well-developed healthcare infrastructure. Additionally, the increased demand for biologics and biosimilars as well as the rising prevalence of chronic diseases have contributed to the expansion of the market in the region. Asia Pacific is expected to a fastest growing region during the forecast period, owing to factors such as a big patient population, increasing demand for biologic pharmaceuticals, government initiatives to support biotechnology research and development, and a growth in contract manufacturing organizations (CMOs) in the region, are driving this expansion.

Major market player included in this report are:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Lonza Group
  • Hoffmann-La Roche Ltd
  • Sartorius AG
  • AstraZeneca
  • Bristol-Myers Squibb
  • Amgen Inc.
  • Gilead Sciences Inc.

Recent Developments in the Market:

  • In January 2023, Fosun Pharma and Shanghai Henlius Biotech announced their agreement for the marketing of serplulimab, an anti-PD-1 monoclonal antibody . The agreement is anticipated to broaden Fosun Pharma's biologics portfolio, as well as its manufacturing and development capabilities, in this quickly expanding market.

Global Mammalian Cell Fermentation Technology Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Application, End Use, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

By Application:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Others

By End Use:

  • Biopharmaceutical Companies
  • CMOs & CDMOs
  • Academic & Research Institutes

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Mammalian Cell Fermentation Technology Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Mammalian Cell Fermentation Technology Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Mammalian Cell Fermentation Technology Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Mammalian Cell Fermentation Technology Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Mammalian Cell Fermentation Technology Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Mammalian Cell Fermentation Technology Market Dynamics

  • 3.1. Mammalian Cell Fermentation Technology Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of chronic diseases
      • 3.1.1.2. Increasing need for novel and secure therapies
      • 3.1.1.3. Growing demand for biologics and biosimilars
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of mammalian cell fermentation technology
      • 3.1.2.2. Stringent government regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancement
      • 3.1.3.2. Increasing research and development spending

Chapter 4. Global Mammalian Cell Fermentation Technology Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Mammalian Cell Fermentation Technology Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Mammalian Cell Fermentation Technology Market by Type, Performance - Potential Analysis
  • 5.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 5.4.1. Hamster Ovary (CHO) Cell Fermentation
    • 5.4.2. Human Embryonic Kidney (HEK) Cell Fermentation
    • 5.4.3. Baby Hamster Kidney (BHK) Cell Fermentation
    • 5.4.4. Murine Myeloma Cell Fermentation
    • 5.4.5. Others

Chapter 6. Global Mammalian Cell Fermentation Technology Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Mammalian Cell Fermentation Technology Market by Application, Performance - Potential Analysis
  • 6.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 6.4.1. Monoclonal Antibodies
    • 6.4.2. Recombinant Proteins
    • 6.4.3. Vaccines
    • 6.4.4. Hormones
    • 6.4.5. Enzymes
    • 6.4.6. Others

Chapter 7. Global Mammalian Cell Fermentation Technology Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Mammalian Cell Fermentation Technology Market by End Use, Performance - Potential Analysis
  • 7.3. Global Mammalian Cell Fermentation Technology Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Mammalian Cell Fermentation Technology Market, Sub Segment Analysis
    • 7.4.1. Biopharmaceutical Companies
    • 7.4.2. CMOs & CDMOs
    • 7.4.3. Academic & Research Institutes

Chapter 8. Global Mammalian Cell Fermentation Technology Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Mammalian Cell Fermentation Technology Market, Regional Market Snapshot
  • 8.4. North America Mammalian Cell Fermentation Technology Market
    • 8.4.1. U.S. Mammalian Cell Fermentation Technology Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Mammalian Cell Fermentation Technology Market
  • 8.5. Europe Mammalian Cell Fermentation Technology Market Snapshot
    • 8.5.1. U.K. Mammalian Cell Fermentation Technology Market
    • 8.5.2. Germany Mammalian Cell Fermentation Technology Market
    • 8.5.3. France Mammalian Cell Fermentation Technology Market
    • 8.5.4. Spain Mammalian Cell Fermentation Technology Market
    • 8.5.5. Italy Mammalian Cell Fermentation Technology Market
    • 8.5.6. Rest of Europe Mammalian Cell Fermentation Technology Market
  • 8.6. Asia-Pacific Mammalian Cell Fermentation Technology Market Snapshot
    • 8.6.1. China Mammalian Cell Fermentation Technology Market
    • 8.6.2. India Mammalian Cell Fermentation Technology Market
    • 8.6.3. Japan Mammalian Cell Fermentation Technology Market
    • 8.6.4. Australia Mammalian Cell Fermentation Technology Market
    • 8.6.5. South Korea Mammalian Cell Fermentation Technology Market
    • 8.6.6. Rest of Asia Pacific Mammalian Cell Fermentation Technology Market
  • 8.7. Latin America Mammalian Cell Fermentation Technology Market Snapshot
    • 8.7.1. Brazil Mammalian Cell Fermentation Technology Market
    • 8.7.2. Mexico Mammalian Cell Fermentation Technology Market
  • 8.8. Middle East & Africa Mammalian Cell Fermentation Technology Market
    • 8.8.1. Saudi Arabia Mammalian Cell Fermentation Technology Market
    • 8.8.2. South Africa Mammalian Cell Fermentation Technology Market
    • 8.8.3. Rest of Middle East & Africa Mammalian Cell Fermentation Technology Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Thermo Fisher Scientific, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Merck KGaA
    • 9.3.3. Danaher Corporation
    • 9.3.4. Lonza Group
    • 9.3.5. Hoffmann-La Roche Ltd
    • 9.3.6. Sartorius AG
    • 9.3.7. AstraZeneca
    • 9.3.8. Bristol-Myers Squibb
    • 9.3.9. Amgen Inc.
    • 9.3.10. Gilead Sciences Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption